RET receptor tyrosine kinase architecture, assemblies, and activation. [PDF]
Zol-Hanlon M, McDonald NQ.
europepmc +1 more source
Clonally Distinct FLT3-TKD Mutations in Host and Donor-Derived AML After Double Cord Blood Transplant: A Case Report. [PDF]
Rojansky RB +3 more
europepmc +1 more source
Efficacy and Safety of Human Epidermal Growth Factor Receptor 2 (HER2) Antibody-Drug Conjugates in Solid Tumors Harboring Non-tyrosine Kinase Domain ERBB2 Mutations: A Systematic Review. [PDF]
Ohta R, Fujimori T, Tanaka K, Hayashi H.
europepmc +1 more source
Clinicopathologic and prognostic value of HER2 alterations in non-small cell lung cancer. [PDF]
Lin Y +6 more
europepmc +1 more source
Effect of Chemical Segregation and Surface Defect Formation on the Mechanism of the Aluminum Dendrite Growth. [PDF]
Liu X +7 more
europepmc +1 more source
Recent advances in the treatment of FLT3-mutated acute myeloid leukemia. [PDF]
Koh JS, Song IC.
europepmc +1 more source
Molecular Markers in AML: Prognostic Implications and Impact on Treatment Decision-Making. [PDF]
Chiusolo P, Maggi R, Alessi A, Sica S.
europepmc +1 more source
SGI-7079 as a novel type I FLT3 inhibitor overcomes resistance to gilteritinib and quizartinib mediated by ITD and TKD mutations in acute myeloid leukemia. [PDF]
Zhong Z +10 more
europepmc +1 more source
Comparative Performance of Electrode Models for Thickness-Shear AT-Cut Quartz Resonators. [PDF]
Chen H +7 more
europepmc +1 more source

